04/17/2025 | Press release | Distributed by Public on 04/17/2025 09:30
FORM C |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL |
|
OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Filer CIK: |
0002008980
|
Filer CCC: |
XXXXXXXX
|
File Number: |
020-33995
|
Period: |
12-31-2024
|
Is this a LIVE or TEST Filing? | LIVE TEST |
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | |
Would you like a Return Copy? |
Name: |
|
Phone Number: |
|
Contact E-Mail Address: |
|
Notify via Filing Website only? |
Name of Issuer: |
Rejuvine Life Sciences, Inc.
|
Form: |
Corporation
|
Jurisdiction of Incorporation/Organization: |
DELAWARE
|
Date of Incorporation/Organization: |
02-09-2023
|
Address 1: |
651 North Broad Street
|
Address 2: |
Suite 201
|
City: |
Middletown
|
State/Country: |
DELAWARE
|
Mailing Zip/Postal Code: |
19709
|
Website of Issuer: |
https://rejuvinelife.sppx.io
|
Current Number of Employees: |
10
|
Total Assets Most Recent Fiscal Year-end: |
4075294.00
|
Total Assets Prior Fiscal Year-end: |
4205052.00
|
Cash and Cash Equivalents Most Recent Fiscal Year-end: |
14169.00
|
Cash and Cash Equivalents Prior Fiscal Year-end: |
30950.00
|
Accounts Receivable Most Recent Fiscal Year-end: |
4000000.00
|
Accounts Receivable Prior Fiscal Year-end: |
4000000.00
|
Short-term Debt Most Recent Fiscal Year-end: |
0.00
|
Short-term Debt Prior Fiscal Year-end: |
0.00
|
Long-term Debt Most Recent Fiscal Year-end: |
3910000.00
|
Long-term Debt Prior Fiscal Year-end: |
3910000.00
|
Revenue/Sales Most Recent Fiscal Year-end: |
47234.00
|
Revenue/Sales Prior Fiscal Year-end: |
4230.00
|
Cost of Goods Sold Most Recent Fiscal Year-end: |
21121.00
|
Cost of Goods Sold Prior Fiscal Year-end: |
-5076.00
|
Taxes Paid Most Recent Fiscal Year-end: |
0.00
|
Taxes Paid Prior Fiscal Year-end: |
17277.00
|
Net Income Most Recent Fiscal Year-end: |
-115455.00
|
Net Income Prior Fiscal Year-end: |
-205500.00
|
Issuer: |
Rejuvine Life Sciences, Inc.
|
Signature: |
Theenathayalan Parthasarathy
|
Title: |
CEO & Founder
|
Signature: |
Theenathayalan Parthasarathy
|
Title: |
CEO & Founder
|
Date: |
04-17-2025
|